AngioWaveNet vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AngioWaveNet

by Angiowave Imaging

AI-ECG Platform

by Shenzhen Carewell Electronics Co., Ltd.

AI Verdict

AngioWaveNet specializes in enhancing fluoroscopic angiograms to improve vessel visualization during cardiac catheterization procedures. In contrast, the AI-ECG Platform focuses on providing AI-powered automatic analysis and diagnosis of 12-lead resting ECGs. While both tools are relevant to cardiology, they address distinct diagnostic and procedural needs, making them adjacent rather than direct competitors.

Choose AngioWaveNet if…

Choose AngioWaveNet if your cardiac catheterization lab requires enhanced real-time or near real-time visualization of blood vessels during fluoroscopic angiograms. This tool is ideal for interventional cardiologists and radiologists seeking to improve clarity and detail in existing angiography systems, seamlessly integrating with current workflows for better procedural guidance.

View AngioWaveNet →

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your practice or emergency department needs an accurate, automated system for the rapid analysis and diagnosis of 12-lead resting ECGs. This platform is best suited for environments where quick and reliable interpretation of common cardiovascular conditions like arrhythmias and myocardial infarction is critical, assisting physicians in high-volume screening or diagnostic settings.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AngioWaveNet	AI-ECG Platform
Pricing	Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available.	Contact for pricing
Deployment	Cloud-based or on-premise/servers	Workstation (with GPU), web-based portal, Windows-based diagnostic client
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet is designed to integrate seamlessly with existing Cath lab workflows and is compatible with any fluoroscopic angiography system, indicating a high degree of adaptability and minimal disruption for specialized users. Its function as a DICOM endpoint further simplifies integration into hospital imaging systems.

Clinical Value

AI-ECG Platform

The AI-ECG Platform provides a clear and quantifiable clinical benefit with over 95% accuracy in diagnosing major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. This high accuracy and rapid diagnosis (approximately 3 seconds) offer significant value in critical care and diagnostic settings.

Pricing & Value

AngioWaveNet

AngioWaveNet offers transparent pricing models, including annual software licensing or subscription-based access, which are tailored to cath lab volume and hospital needs, with custom packages available. In contrast, the AI-ECG Platform only states 'contact for pricing,' lacking transparency.

Enterprise Readiness

AngioWaveNet

AngioWaveNet explicitly states it is HIPAA compliant and offers flexible deployment options (cloud-based or on-premise/servers), functioning as a DICOM endpoint for imaging systems. While the AI-ECG Platform is FDA-cleared and supports various data formats, its HIPAA compliance and BAA status are only 'likely' and not explicitly confirmed, which is a significant consideration for enterprise adoption.

Innovation

AngioWaveNet

AngioWaveNet utilizes AI-powered Spatiotemporal Enhancement Processing (STEPu2122) to improve vessel visualization in dynamic fluoroscopic angiograms, addressing a complex challenge in real-time procedural guidance. This specialized image enhancement for high-stakes interventional cardiology procedures represents a highly innovative application of AI.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer specific details regarding the level of support, service level agreements (SLAs), or comprehensive documentation for either AngioWaveNet or the AI-ECG Platform. Therefore, a distinction cannot be made based on the available data.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AngioWaveNet	AI-ECG Platform
Name	AngioWaveNet	AI-ECG Platform
Company	Angiowave Imaging	Shenzhen Carewell Electronics Co., Ltd.
Primary Application/Focus	Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories.	AI automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs.
Key Technology/Method	AI-powered Spatiotemporal Enhancement Processing (STEPu2122); Post-processing AI for angiographic images.	AI-powered automatic ECG analysis and diagnosis; Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
Vendor Agnostic	Compatible with any fluoroscopic angiography system (vendor-agnostic).	Hardware independent, compatible with most ECG machines.
Input Data Formats/Compatibility	Functions as a DICOM endpoint for imaging systems.	Supports various ECG data formats: Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG.

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and AI-ECG Platform.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of AngioWaveNet compared to the AI-ECG Platform?

AngioWaveNet is FDA-cleared AI software designed to enhance fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. The AI-ECG Platform is an FDA-cleared AI system for automatic analysis and diagnosis of 12-lead resting ECGs, assisting physicians in interpretation.

How do these tools integrate with existing medical equipment and workflows?

AngioWaveNet integrates with existing Cath lab workflows, is compatible with any fluoroscopic angiography system (vendor-agnostic), and functions as a DICOM endpoint for imaging systems. The AI-ECG Platform is hardware independent, compatible with most ECG machines, and supports various ECG data formats including Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG.

Which medical specialties are targeted by AngioWaveNet versus the AI-ECG Platform?

AngioWaveNet is designed to support specialties such as Cardiology, Interventional Radiology, and Vascular Surgery. The AI-ECG Platform targets Cardiology, Emergency Medicine, and Internal Medicine.

What specific AI-powered features do these tools offer to assist physicians?

AngioWaveNet provides AI-powered Spatiotemporal Enhancement Processing (STEPu2122) to enhance the visibility of blood vessels, vascular structures, and anatomical features in angiographic images. The AI-ECG Platform offers AI-powered automatic ECG analysis and diagnosis, claiming over 95% accuracy in diagnosing major cardiovascular diseases like arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, with rapid diagnosis in approximately 3 seconds.